CONDENSED CONSOLIDATED STATEMENT OF EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	AOCI Attributable to Parent
Beginning Balance at Dec. 31, 2016	$ 1,957,423	$ 0	$ 0	$ 0	$ 0
Beginning Balance, common stock, shares outstanding (in shares) at Dec. 31, 2016		0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(16,879)
Redemption of Series A Preferred Stock	(1,153)
Distribution of Class B notes receivable	(19,686)
Cancelation/distribution of Class B notes receivable	19,686
Share-based compensation expense	12,001
Accrued interest on Class B notes	15
Ending Balance, common stock, shares outstanding (in shares) at Jan. 31, 2017		0
Ending Balance at Jan. 31, 2017	1,951,407	$ 0	0	0	0
Beginning Balance at Dec. 31, 2016	1,957,423	$ 0	0	0	0
Beginning Balance, common stock, shares outstanding (in shares) at Dec. 31, 2016		0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(42,391)
Total other comprehensive income	$ 13,272
Ending Balance, common stock, shares outstanding (in shares) at Mar. 31, 2017	310,376,634	310,376,634
Ending Balance at Mar. 31, 2017	$ 3,658,042	$ 3,104	3,667,178	(25,512)	13,272
Beginning Balance at Jan. 31, 2017	1,951,407	$ 0	0	0	0
Beginning Balance, common stock, shares outstanding (in shares) at Jan. 31, 2017		0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Pre-IPO Transactions (see Note 1)	(1,951,407)	$ 2,218	1,949,189
Pre-IPO Transactions (see Note 1) (in shares)		221,826,634
Issuance of Common Stock — IPO (in shares)		88,550,000
Issuance of Common Stock — IPO	1,692,058	$ 886	1,691,172
Offering costs	(5,426)		(5,426)
Net loss	(25,512)			(25,512)
Share-based compensation expense	32,243		32,243
Total other comprehensive income	$ 13,272				13,272
Ending Balance, common stock, shares outstanding (in shares) at Mar. 31, 2017	310,376,634	310,376,634
Ending Balance at Mar. 31, 2017	$ 3,658,042	$ 3,104	$ 3,667,178	$ (25,512)	$ 13,272